236 related articles for article (PubMed ID: 29938473)
1. Willingness to Pay for Colorectal Cancer Screening and Effect of Copayment in Southern Thailand.
Saengow U; Birch S; Geater A; Chongsuwiwatvong V
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1727-1734. PubMed ID: 29938473
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
4. The economic evaluation of screening for colorectal cancer: Case of Iran.
Barouni M; Ghaderi H; Shahmoradi MK
Clin Lab; 2013; 59(5-6):667-74. PubMed ID: 23865368
[TBL] [Abstract][Full Text] [Related]
5. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
6. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
[TBL] [Abstract][Full Text] [Related]
7. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
Ladabaum U; Mannalithara A; Mitani A; Desai M
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.
Ladabaum U; Mannalithara A; Jandorf L; Itzkowitz SH
Cancer; 2015 Apr; 121(7):1088-97. PubMed ID: 25492455
[TBL] [Abstract][Full Text] [Related]
11. Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in Thailand.
Phisalprapa P; Ngorsuraches S; Wanishayakorn T; Kositamongkol C; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2021; 24(1):226-233. PubMed ID: 33467947
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
Peterse EFP; Meester RGS; de Jonge L; Omidvari AH; Alarid-Escudero F; Knudsen AB; Zauber AG; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2021 Feb; 113(2):154-161. PubMed ID: 32761199
[TBL] [Abstract][Full Text] [Related]
13. Preferences and acceptance of colorectal cancer screening in Thailand.
Saengow U; Chongsuwiwatvong V; Geater A; Birch S
Asian Pac J Cancer Prev; 2015; 16(6):2269-76. PubMed ID: 25824749
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.
Aronsson M; Carlsson P; Levin LÅ; Hager J; Hultcrantz R
Br J Surg; 2017 Jul; 104(8):1078-1086. PubMed ID: 28561259
[TBL] [Abstract][Full Text] [Related]
17. The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.
Wong MC; Ching JY; Chan VC; Sung JJ
Sci Rep; 2015 Sep; 5():13568. PubMed ID: 26338314
[TBL] [Abstract][Full Text] [Related]
18. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
19. Value Of Waiving Coinsurance For Colorectal Cancer Screening In Medicare Beneficiaries.
Peterse EFP; Meester RGS; Gini A; Doubeni CA; Anderson DS; Berger FG; Zauber AG; Lansdorp-Vogelaar I
Health Aff (Millwood); 2017 Dec; 36(12):2151-2159. PubMed ID: 29200350
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
